Siemens Healthineers (OTCMKTS:SMMNY) Shares Up 0.6% – Time to Buy?

Siemens Healthineers AG (OTCMKTS:SMMNY) was up 0.6% during mid-day trading on Monday. The stock traded as high as $23.66 and last traded at $23.58. 56,932 shares traded hands during trading, a decline of 57% from the average session volume of 131,594 shares. The stock had previously closed at $23.44.

Wall Street Analyst Weigh In

SMMNY has been the subject of several recent research reports. Royal Bank Of Canada reissued an “outperform” rating on shares of Siemens Healthineers in a research report on Friday, October 16th. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a research report on Tuesday, October 13th. Zacks Research lowered shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 1st. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Siemens Healthineers in a report on Tuesday, August 18th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Siemens Healthineers has an average rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

The company has a 50 day moving average of $22.35 and a two-hundred day moving average of $22.09.

About Siemens Healthineers

Siemens Healthineers AG is a global medical technology company headquartered in Erlangen, Germany. The company develops, manufactures and provides products, services and digital solutions that support the prevention, diagnosis and treatment of disease. Siemens Healthineers operates as a separately managed company within the broader Siemens group and has served healthcare providers in markets around the world.

Its portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, X-ray and molecular imaging equipment, as well as ultrasound systems.